Oscar Health, Inc. short interest in 2024
In 2024, Oscar Health, Inc.'s disclosed short interest ran from 2.34% of shares outstanding on 12 Jan 2024 to 7.71% on 31 Dec 2024, a change of +5.37 percentage points. The year's high was 7.90% on 13 Dec 2024 and its low 2.29% on 15 Feb 2024, averaging 4.79% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.86 days on 30 Aug 2024. Full history: Oscar Health, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 2.34% (12 Jan 2024)
- End of year
- 7.71% (31 Dec 2024)
- Change
- +5.37 pp
- High
- 7.90% (13 Dec 2024)
- Low
- 2.29% (15 Feb 2024)
- Average
- 4.79%
- Highest days to cover
- 7.86 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 2.34% | 1.40 | results (8-K) |
| 31 Jan 2024 | 2.76% | 2.04 | |
| 15 Feb 2024 | 2.29% | 1.16 | results (8-K), 10-K filed |
| 29 Feb 2024 | 2.37% | 1.72 | |
| 15 Mar 2024 | 2.75% | 1.87 | |
| 28 Mar 2024 | 3.02% | 2.98 | |
| 15 Apr 2024 | 3.33% | 3.53 | |
| 30 Apr 2024 | 2.87% | 2.31 | |
| 15 May 2024 | 2.34% | 1.23 | 10-Q filed, results (8-K) |
| 31 May 2024 | 3.22% | 2.61 | |
| 14 Jun 2024 | 4.91% | 3.15 | |
| 28 Jun 2024 | 5.46% | 2.94 | |
| 15 Jul 2024 | 6.06% | 5.28 | |
| 31 Jul 2024 | 7.14% | 6.39 | |
| 15 Aug 2024 | 7.31% | 5.29 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 7.38% | 7.86 | |
| 13 Sep 2024 | 5.24% | 3.62 | |
| 30 Sep 2024 | 4.97% | 3.81 | |
| 15 Oct 2024 | 5.11% | 4.71 | |
| 31 Oct 2024 | 5.02% | 4.04 | |
| 15 Nov 2024 | 6.72% | 2.48 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 6.85% | 4.12 | |
| 13 Dec 2024 | 7.90% | 4.08 | |
| 31 Dec 2024 | 7.71% | 5.33 |
See also: Oscar Health, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.